CME Group Inc.
CME
$276.29
$2.290.84%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Revenue | 5.85B | 5.70B | 5.64B | 5.41B | 5.27B |
Total Other Revenue | 428.20M | 421.90M | 398.20M | 373.80M | 345.00M |
Total Revenue | 6.27B | 6.12B | 6.03B | 5.79B | 5.62B |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | 6.27B | 6.12B | 6.03B | 5.79B | 5.62B |
SG&A Expenses | 1.65B | 1.65B | 1.63B | 1.59B | 1.58B |
Depreciation & Amortization | 334.00M | 336.80M | 339.70M | 344.10M | 349.20M |
Other Operating Expenses | 201.20M | 200.80M | 194.10M | 187.20M | 185.50M |
Total Operating Expenses | 2.19B | 2.18B | 2.16B | 2.12B | 2.11B |
Operating Income | 4.09B | 3.94B | 3.87B | 3.67B | 3.50B |
Income Before Tax | 4.67B | 4.54B | 4.45B | 4.25B | 4.11B |
Income Tax Expenses | 1.05B | 1.02B | 985.00M | 945.00M | 912.50M |
Earnings from Continuing Operations | 3.63K | 3.53K | 3.47K | 3.30K | 3.20K |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | 3.63B | 3.53B | 3.47B | 3.30B | 3.20B |
EBIT | 4.09B | 3.94B | 3.87B | 3.67B | 3.50B |
EBITDA | 4.42B | 4.27B | 4.21B | 4.01B | 3.85B |
EPS Basic | 9.96 | 9.69 | 9.52 | 9.08 | 8.79 |
Normalized Basic EPS | 8.11 | 7.88 | 7.74 | 7.39 | 7.15 |
EPS Diluted | 9.94 | 9.67 | 9.51 | 9.07 | 8.79 |
Normalized Diluted EPS | 8.10 | 7.87 | 7.73 | 7.38 | 7.14 |
Average Basic Shares Outstanding | 1.44B | 1.44B | 1.44B | 1.44B | 1.44B |
Average Diluted Shares Outstanding | 1.44B | 1.44B | 1.44B | 1.44B | 1.44B |
Dividend Per Share | 4.70 | 4.60 | 4.55 | 4.50 | 4.45 |
Payout Ratio | 105.42% | 101.66% | 102.88% | 107.38% | 110.34% |